T1	intervention 18 27	boswellia
T2	intervention 29 36	betaine
T4	No-of-participants 1177 1188	seventy-six
T5	eligibility 1189 1208	premenopausal women
T6	control 1239 1246	placebo
T3	intervention 41 53	myo-inositol
T7	duration 1293 1303	six months
T8	outcome 1414 1438	breast density reduction
T9	intervention-value 1440 1443	60%
T10	control-value 1448 1450	9%
